Serenity’s mission is to change the pharmaceutical landscape with unorthodox ideas that are safe and effective. They are beginning this venture by improving the capabilities of gene therapy, using a completely novel approach to immunomodulation. CargoTek™ improves gene therapies by inducing a state of tolerance and dampening adverse pro-inflammatory reactions. Serenity’s platform technology can also address unmet needs in other therapeutic areas, such as protein based-therapeutics, cell therapies, and/or transplants.
Kitchener, Ontario
